CTOs on the Move

Avrobio

www.avrobio.com

 
AVROBIO`s vision is to bring personalized gene therapy to the world. We aim to prevent, halt or reverse disease throughout the body with a single dose of gene therapy designed to drive durable expression of therapeutic protein, even in hard-to-reach tissues and organs including brain, muscle and bone. Our ex vivo lentiviral gene therapy pipeline includes clinical programs in Fabry disease, Gaucher disease type 1 and cystinosis, as well as preclinical programs in Hunter syndrome, Gaucher disease type 3 and Pompe disease. AVROBIO is powered by our industry leading plato® gene therapy platform, our foundation designed to deliver gene therapy ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.avrobio.com
  • One Kendall Square Building 300, Suite 201
    Cambridge, MA USA 02139
  • Phone: 617.914.8420

Executives

Name Title Contact Details
Kim Raineri
Chief Manufacturing and Technology Officer Profile
Kim Raineri
Chief Manufacturing and Technical Operations Officer Profile

Funding

Avrobio raised $25M on 08/03/2016
Avrobio raised $60M on 02/01/2018

Similar Companies

Kymanox

Kymanox is a professional services organization with a focus on project delivery. Our team of experts provide guide you and your project.

MBL

MBL is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novara Tesija Michela and Priehs

Novara Tesija Michela and Priehs is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Partner Therapeutics

Partner Therapeutics is devoted to developing and commercializing cancer medicines and combination therapies that can make a meaningful difference in the lives of cancer patients.

BioGenex Laboratories, Inc.

BioGenex Laboratories, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.